logo
Women on Weight-Loss Drugs Warned of Surprise 'Ozempic Babies'

Women on Weight-Loss Drugs Warned of Surprise 'Ozempic Babies'

Newsweek2 days ago

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
Women taking popular weight-loss drugs have been urged to use effective contraception while taking the medication amid reports of a so-called "Ozempic babies" phenomenon.
The advice was issued by the United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA), an executive agency of the Department of Health and Social Care, on Thursday.
Newsweek reached out to the U.S. Department of Health and Human Services for comment via email.
Why It Matters
Demand for weight-loss drugs, including GLP-1 medications such as Ozempic, Wegovy, and Mounjaro, has surged in the United States. In May 2024, a KFF Health Tracking Poll found that approximately 6 percent of American adults—about 15 million people—were using GLP-1 agonists such as Ozempic, either for diabetes treatment or weight loss.
Some experts have cautioned that women should use effective contraception while taking these medications amid reports that they may be linked to an increase in unexpected pregnancies, The Guardian reported last May.
A person injects Ozempic into their abdomen on October 10, 2024, in Sydney, Australia.
A person injects Ozempic into their abdomen on October 10, 2024, in Sydney, Australia.
Steve Christo - Corbis/Corbis/Getty Images
What To Know
The MHRA issued its alert after receiving 40 reports related to pregnancies while using "GLP-1 medicines," which are known by the brand names Ozempic, Mounjaro, Wegovy, Saxenda, and Victoza.
Ozempic and Wegovy contain semaglutide, which mimics the GLP-1 hormone to increase insulin, slow digestion, and suppress appetite. Mounjaro contains tirzepatide, which acts on an additional hormone related to blood sugar and appetite control.
The MHRA warned that Mounjaro may reduce the effectiveness of oral contraceptives in people who are overweight. It received 26 pregnancy-related reports for Mounjaro alone.
"Therefore, those taking Mounjaro who are overweight and are using an oral form of contraception are advised to also use a non-oral form of contraception," the agency said. "This only applies to those taking Mounjaro and is especially important for the four weeks after starting Mounjaro and after any dose increase."
Hundreds of women have shared personal accounts of unplanned pregnancies while using these medications in online groups, including the Facebook group "I got pregnant on Ozempic."
"My ozempic baby...I see so many posts about ozempic and asking for "stories or side effects," but I never see anyone warning about pregnancy... lol," one woman shared on Facebook.
"If you don't know, I got pregnant on ozempic and so many other women have too..I was on ozempic for 6 weeks & found out I was pregnant. I was so scared, google had me frightened I would miscarry because of the ozempic. I then came across a group called 'I got pregnant on ozempic'. I started reading all of these stories about women fighting infertility and getting pregnant on ozempic."
The Food and Drug Administration has not yet issued similar advisories in the United States.
What People Are Saying
MHRA Chief Safety Officer Dr. Alison Cave said: "Skinny jabs are medicines licensed to treat specific medical conditions and should not be used as aesthetic or cosmetic treatments. They are not a quick fix to lose weight, and have not been assessed to be safe when used in this way.
"Our guidance offers patients a 'one stop shop' for our up-to-date advice on how to use these powerful medicines safely.
"This guidance should not be used as a substitute to reading the patient information leaflet or having a conversation with a healthcare professional as part of the prescribing process."
Dr. Ilana Ressler, a reproductive endocrinologist at Illume Fertility, told Interesting Engineering on May 22: "There is this phenomenon of Ozempic babies...really what I think what's happening is women who may not have been ovulating before with the improvements that the medication is bringing on, that might be helping them to ovulate more regularly and they might be more likely to conceive while on the medication than not—so it is recommended to avoid pregnancy while taking the medication."
Dr. Zuri A. Murrell, in a video on X last year: "There is nothing magical about the medicine that's in Ozempic that helps you get pregnant. But what it does is that a lot of times, when people can't, it's because of a hormone weight imbalance.
"And so, when you lose weight, and sometimes when you lose weight rapidly, the hormones and the new you aren't in concert. Or they really are in concert, and guess what can happen, pregnancy.
"So, it's not the Ozempic itself, it is actually the balancing out of your hormones. That means that you've lost fat, and that the body actually for you is working like it should. So just remember, Ozempic is not something that somebody takes and 'I'm pregnant.' What it does do is cause your body and hormone level to be more in sync and more likely that you can."
What Happens Next
It remains unclear whether the FDA will follow the MHRA's lead in issuing similar warnings or guidance on contraception.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

FBI Working With India to Disrupt Chinese Fentanyl Network—Kash Patel
FBI Working With India to Disrupt Chinese Fentanyl Network—Kash Patel

Newsweek

time2 hours ago

  • Newsweek

FBI Working With India to Disrupt Chinese Fentanyl Network—Kash Patel

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Federal Bureau of Investigation (FBI) Director Kash Patel told podcaster Joe Rogan during a Friday episode that the agency is working with the Indian government to dismantle global fentanyl networks, which he said originate in China. Newsweek has reached out to the FBI's press office, the Indian Government's Ministry of External Affairs, and the Chinese Embassy in Washington for comment via email on Saturday. Why It Matters President Donald Trump has made combating the opioid crisis, particularly the influx of illicitfentanyl, a central focus of his administration's policies. Earlier this year, to address the sources of fentanyl trafficking, Trump imposed tariffs on imports from China, Mexico, and Canada. There are some legitimate medical uses for fentanyl. The opioid crisis has far-reaching impacts across the country. In 2024, the United States witnessed a significant decrease in opioid-related overdose deaths, dropping from 110,037 in 2023 to 80,391 in 2024, according to data from the U.S. Centers for Disease Control and Prevention (CDC). Rogan, host of The Joe Rogan Experience podcast, is one of the most-listened-to media figures, drawing an audience of roughly 11 million listeners. What To Know Patel told Rogan that when he joined the bureau, he launched a "massive enterprise" to target companies in China that manufacture "fentanyl precursors." He said that while China may not produce the drug in its final form, it supplies the key ingredients used to make fentanyl, calling the country the "root of the problem." The U.S.-China Economic and Security Review Commission, which provides recommendations to Congress, stated in an August 2021 finding that "China remains the primary country of origin for illicit fentanyl and fentanyl-related substances trafficked into the United States." Patel said during the interview with Rogan that the country has been shipping the precursors "to places like India—and I'm also doing operations in India—and they're having the Mexican cartels now make this fentanyl down in Mexico." In March, the Chinese government published a white paper laying out its purported efforts to crack down on fentanyl trade and hit back at U.S. criticism as Washington imposed tariffs over the issue. "I literally just got off the phone with the Indian government, I said: 'I need your help. This stuff's coming into your country and then they're moving it from your country because India's not consuming fentanyl...I need you and your help,'" the FBI director told Rogan. He explained the FBI is "working with the heads of their [the Indian] government, law enforcement authorities to say, 'We're going to find these companies that buy it and we're going to shut them down. We're going to sanction them; we're going to arrest them where we can. We're going to indict them in America if we can. We're going to indict them in India if we can.'" He reiterated that "this is a global problem." Patel said the Chinese Communist Party (CCP) isn't partaking in the trade for profitability reasons, but rather, "in my opinion, the CCP have used it as a directed approach because we are their their long-term game is how do I, in my opinion, kneecap the United States of America, our largest adversary?" suggesting that the drug allows them to "take out generations of young men and women." Tensions between Washington and Beijing have been high over a slew of issues, including tariff policies and national security issues. In May, federal authorities arrested 16 individuals and seized over 400 kilograms of the drug in the largest fentanyl bust in Drug Enforcement Administration (DEA) history. FBI Director Kash Patel is seen in Washington on May 8. FBI Director Kash Patel is seen in Washington on May 8. AP Photo/Jose Luis Magana What People Are Saying U.S. Treasury Secretary Scott Bessent told CNBC in mid-May: "I have a personal stake in this. There are two very close friends [who] lost children to this terrible scourge. Hundreds of thousands of Americans die every year. And I think that we saw here in Geneva the Chinese are now serious about assisting the U.S. in stopping the flow of precursor drugs." A spokesperson for the Chinese foreign ministry said in March: "Facts speak louder than words. The U.S. is spreading all kinds of false information on the fentanyl issue, smearing and scapegoating China, and hiking tariffs on Chinese imports over fentanyl." President Donald Trump wrote in an April 24 Truth Social post: "...By the way, Fentanyl continues to pour into our Country from China, through Mexico and Canada, killing hundreds of thousands of our people, and it better stop, NOW!" What Happens Next? It is unclear what the partnership looks like, but according to Patel it is ongoing.

‘Harmful' TikTok trend fueling new wave of ‘dangerous' diet culture
‘Harmful' TikTok trend fueling new wave of ‘dangerous' diet culture

New York Post

time4 hours ago

  • New York Post

‘Harmful' TikTok trend fueling new wave of ‘dangerous' diet culture

TikTok has long been a breeding ground for viral trends, but its latest subculture, 'SkinnyTok,' is reigniting old diet culture in a digital age. Behind the trendy filters and catchy sounds lies an extremely problematic reality – a community where thinness is idolised, extreme calorie deficits are glamorised, and the pursuit of a shrinking body is celebrated, often at the expense of mental and physical health. The rise of SkinnyTok Advertisement SkinnyTok refers to a corner of the internet where creators openly document their weight loss journeys, post 'what I eat in a day' videos featuring alarmingly low calorie counts, and share 'body checks' (videos where people weigh and measure themselves). Some even boast about 'gaslighting' themselves into being skinny, or confess to daily gym visits out of a fear of being 'fat' – even when they already fit society's narrow beauty standards. TikTok has, for its part, attempted to clamp down on this content. 5 TikTok has long been a breeding ground for viral trends, but its latest subculture, 'SkinnyTok,' is reigniting old diet culture in a digital age. Volodymyr – Advertisement Searching for 'SkinnyTok' now triggers a warning: 'You're not alone' and prompts people to seek help if they're struggling with body image, food, or exercise. Influencers like Liv Schmidt, who built a following of over 670,000 with her 'blonde and skinny' persona, have been banned. Yet, the algorithm still seems to serve up the very content it claims to protect users from. So, what can people do to safeguard themselves online? Advertisement First, you need to understand what SkinnyTok is, how the trend has managed to gain such a huge following, and who is most at risk. 5 Searching for 'SkinnyTok' now triggers a warning: 'You're not alone' and prompts people to seek help if they're struggling with body image, food, or exercise. Odua Images – The personal toll Jemma Haythorne, a confidence coach, speaker, and podcaster, knows firsthand the damage that online diet culture can do. 'I started hating my body when I was 12 years old, but really spiralled into disordered eating when I was 16. My friends and I would follow skinny content on Tumblr, using it as 'motivation' to eat less to achieve our goals of being thin,' she tells Advertisement For Haythorne, the pressure peaked during Schoolies, when the prospect of hundreds of Facebook photos led her to subsist on scarily low calories and avoid water to prevent 'bloating' – all ideas she picked up from social media. 'Instagram then became a dangerous place too for someone with body image issues and a fraught relationship with food,' she says, adding that the rise of fitness influencers and 'clean eating' trends was fuel for her already disordered behaviors. Her lowest point came between 2017 and 2019. 'Social media told me that everyone was thin, gorgeous, tanned, hairless, toned, and successful, because that's what the algorithm was serving me, and those were the people who were platformed,' she says. 'The message that I received was that I was failing, because no matter how hard I tried, I couldn't meet those standards.' Haythorne believes that without social media, she would never have developed an eating disorder, depression, and anxiety to the extent she did. The cyclical nature of online trends She says she has witnessed body ideals shift over the years, from ultra-thin, to athletic and toned, to the 'Kim Kardashian' hourglass, and now back to just 'plain thin.' Advertisement Despite the rise of the body positivity movement, she's sceptical about its real-world impact: 'The body ideal has always come back to being in a smaller body — something that I desperately hope we can change in the future.' The influencer effect Influencers and content creators play a massive role in shaping body image perceptions, Haythorne argues. 5 Psychologist Carly Dober confirms that SkinnyTok can trigger and exacerbate disordered eating behaviors and eating disorders. Kate – 'Those who post content that encourages unhealthy relationships with food and bodies are directly damaging their audience. SkinnyTok content is incredibly problematic and harmful, and when this becomes trendy, it becomes dangerous, especially for those who don't have the knowledge and understanding of how damaging it is.' Advertisement But the damage isn't always obvious. Seemingly innocuous 'before and after' photos reinforce the idea that smaller is better, while meal inspiration videos suggest that copying someone's diet will yield the same body. 'Any form of editing of bodies or faces makes people think they need to live up to looking like that in order to be beautiful or worthy, yet the person themselves doesn't even look like that,' she notes. She claims that while platforms like TikTok and Instagram have a responsibility to manage the harm they promote, individual influencers must also be aware of their impact. The psychological impact Advertisement Psychologist Carly Dober confirms that SkinnyTok can trigger and exacerbate disordered eating behaviors and eating disorders. 'These trends influence how people perceive and evaluate their own bodies, and the bodies of others. Behaviorally, people may self-isolate, which can also impact their work, education, and relationships,' she explains. Beyond the psychological impact, the physical consequences are dire too. Eating disorders can harm the heart, digestive system, bones, teeth, and mouth. Advertisement Typical serious side effects include low blood pressure, slow or irregular heartbeats, feeling tired, weak, dizzy, or faint, constipation and bloating, irregular periods, and weak bones. Who's most at risk? According to Dober, certain groups are especially vulnerable to the dangers of SkinnyTok. These include: – Adolescents (especially those aged 12–25) with a median age of 18 – Women during key transition periods (e.g. finishing school) 5 'SkinnyTok content is incredibly problematic and harmful, and when this becomes trendy, it becomes dangerous, especially for those who don't have the knowledge and understanding of how damaging it is,' experts said. LIGHTFIELD STUDIOS – – Women with Polycystic Ovary Syndrome or diabetes – Athletes and those in appearance-focused activities like dancing – People with a family history of eating disorders – Anyone seeking help for weight loss or who has engaged in dieting or disordered eating The role of TikTok's culture Qualified nutritionist Yaz Jackson sees SkinnyTok as part of a broader trend of 'normalizing' harmful behaviors on TikTok. She notes that TikTok's culture is different from Instagram's: 'You can 'get away' with more. It's more of a diary, people feel like they can say whatever, and it's lighthearted, and nobody judges. I've seen creators say things like 'I could never share this on Insta, they'd judge me, but I can tell you guys,'' Jackson believes there's a trend of radical honesty emerging on TikTok, where creators are praised for sharing 'the tea' – the secrets behind their appearance, whether it's the use of medication, diets, or cosmetic surgery. Their content is being favoured, as people applaud them for being 'real' and 'not fake' – i.e., unlike the countless models and celebrities who pretend they eat pizza and burgers when the reality is much different. 'This trend then gains traction because when enough people make something okay to talk about again, they feel safer,' she said. 'Things that were once stigmatized are now being accepted – but only if you are super honest and transparent about it. People love that.' The dangers of unqualified advice Dr. Zac, a GP, urges people to exercise caution when seeking health advice online, especially when it comes from unqualified creators. 'Health advice should come from qualified professionals – doctors, registered dietitians, clinical psychologists – people with actual credentials, not just abs and a ring light. If someone's offering drastic weight loss 'hacks' or pushing extreme transformations, especially if they're profiting from it, be wary,' he says. Things to look out for include: 'Are they citing evidence-based sources? Do they promote balance over extremes? Are they championing sustainable health, or quick fixes and aesthetic perfection?' How to safeguard your mental health Dober and Zac recommend several strategies for protecting yourself online: Curate your feed: Block or mute content and creators that promote unhealthy behaviors 5 SkinnyTok refers to a corner of the internet where creators openly document their weight loss journeys, post 'what I eat in a day' videos featuring alarmingly low calorie counts, and share 'body checks.' Floral Deco – Use platform tools: Filter out triggering keywords where possible Limit screen time: Reduce endless scrolling to avoid algorithm rabbit holes Follow positive accounts: Such as ones that promote body neutrality, mental health, and self-compassion Seek support: If you're struggling, reach out to a psychologist or trusted professional. And as Zac puts it: 'Healing starts when we stop punishing ourselves and start listening to what our body and mind actually need.'

Lilly partners with Camurus in search of a long-lasting obesity drug
Lilly partners with Camurus in search of a long-lasting obesity drug

Yahoo

time4 hours ago

  • Yahoo

Lilly partners with Camurus in search of a long-lasting obesity drug

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Looking to defend its giant cardiometabolic health franchise, Eli Lilly is licensing a technology from Swedish biotechnology firm Camurus that promises to produce longer-acting medications. Camurus' FluidCrystal technology is designed to methodically release a therapeutic drug substance into the body over a period of days or months. After an injection, the solution interacts with bodily fluids to transform into a liquid crystalline gel. The gel holds the active ingredient and then slowly degrades, releasing medicine. The deal includes an unspecified upfront payment as part of an initial package that may be worth as much as $290 million, Camurus said Tuesday. That figure also includes payments for reaching certain development and regulatory milestones. Another $580 million could be available for meeting sales goals, along with mid-single digit royalties for successful products. Lilly and rival Novo Nordisk revolutionized diabetes and obesity treatment over the last few years with GLP-1 medicines that opened up one of the biggest markets the pharmaceutical industry has ever seen. In the first quarter alone, Lilly raked in more than $6 billion from sales of tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity. Novo brought in even more from its Ozempic and Wegovy. Now Lilly and Novo are faced with defending the market as a raft of competitors vie to offer newer and better options. Both companies have bulked up their pipelines; Lilly recently claimed success in a Phase 3 trial of a GLP-1 medicine that can be taken in pill form instead of injection. It also has a triple-acting drug in development and a number of other experimental medicines that work differently. The Camurus deal allows Lilly to apply the long-acting technology to as many as four of its drug compounds. That may help the company stave off competitors such as Metsera, which in January announced promising research for its experimental long-acting GLP-1 shot. Meanwhile, Roche recently announced a $1.65 billion deal to expand its obesity pipeline and Amgen and Viking Therapeutics are both moving into late-stage studies of potential rival treatments. Companies are also working on ways to augment the Lilly and Novo medicines. Veru is testing a drug designed to help preserve muscle when taken with Novo's Wegovy. Regeneron and others are conducting similar research. Recommended Reading Novo inks Ascendis deal to develop long-acting GLP-1, other metabolic drugs

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store